Trilogy Therapeutics

Trilogy Therapeutics

Biotechnology, 4653 Carmel MTN Rd, San Diego, California, 92130, United States, 1-10 Employees

trilogytherapeutics.com

  • LinkedIn

phone no Phone Number: 20********

Who is TRILOGY THERAPEUTICS

Trilogy Therapeutics develops lung targeted therapy to prevent and treat severe respiratory diseases. Many respiratory diseases are treated with intravenous or oral agents so that only a ...

Read More

map
  • 4653 Carmel MTN Rd, San Diego, California, 92130, United States Headquarters: 4653 Carmel MTN Rd, San Diego, California, 92130, United States
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from TRILOGY THERAPEUTICS

Trilogy Therapeutics Org Chart and Mapping

Employees

Grace Yu

President & CEO, Co-Founder

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Trilogy Therapeutics

Answer: Trilogy Therapeutics's headquarters are located at 4653 Carmel MTN Rd, San Diego, California, 92130, United States

Answer: Trilogy Therapeutics's phone number is 20********

Answer: Trilogy Therapeutics's official website is https://trilogytherapeutics.com

Answer: Trilogy Therapeutics's revenue is Under $1 Million

Answer: Trilogy Therapeutics's SIC: 2834

Answer: Trilogy Therapeutics's NAICS: 325412

Answer: Trilogy Therapeutics has 1-10 employees

Answer: Trilogy Therapeutics is in Biotechnology

Answer: Trilogy Therapeutics contact info: Phone number: 20******** Website: https://trilogytherapeutics.com

Answer: Trilogy Therapeutics develops lung targeted therapy to prevent and treat severe respiratory diseases. Many respiratory diseases are treated with intravenous or oral agents so that only a relatively small amount of drug is actually delivered to the lung. As the lung is the primary site of infection, the efficacy of these systemic treatments is suboptimal. Trilogy Therapeutic is focused on achieving optimal efficacy by developing lung compatible formulations that are suitable for aerosolization in order to target deposition at the site of disease and avoid the side-effects of systemic distribution.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access